FDA Clears First-of-Their Kind Tests To Help Identify Concussions
By Emily Mullin
Public awareness about the risks of concussions may be on the rise, but many concussions are still flying under the radar of health professionals. This week, the FDA has sanctioned two computerized tests, the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) and ImPACT Pediatric, that may be able to help.
In recent years, the National Institutes of Health and Department of Defense have helped spur development in concussion research, and companies like Abbott, Banyan Biomarkers and Quanterix are also investigating diagnostic blood tests. But so far, none have been approved by the FDA.
Read the remainder of the article at Forbes.
Share this page